MLL gene in adults T-ALL is recurrent, with an incidence of more than 8%. In view of these results and the fact that lymphoblastic leukemia with MLL translocation seems to constitute a distinct disease with a poor prognosis, we would recommend that adults with T-ALL be screened by FISH analysis for MLL abnormalities.
To the editor:
Implication for how the single nucleotide polymorphism (SNP) of Fc receptor, Fc␥RIIIa alters the interaction with anti-CD20 monoclonal antibody
We read a recent interesting article by Cartron et al. 1 The article indicated that the single nucleotide polymorphism (SNP) of IgG Fc receptor Fc␥RIIIa (FCGR3A) molecule affects clinical outcome of anti-CD20 monoclonal antibody therapy for follicular nonHodgkin lymphoma. 1 We created homology models of variant FCGR3A molecules based on homology between variant FCGR3A and known 3-dimensional structure of soluble CD16. 2 Each model was superimposed onto a 1:1 complex of soluble CD16 and Fc fragment of human IgG1 ( Figure 1A-B) . These models indicate that the position of variation 158Val/Phe exists at the F-G loop of the molecules that serves as binding interface and is surrounded by both chains of Fc fragments of IgG1 ( Figure 1C ). Since the side chain of Phe is hydrophobic and quite bigger than that of Val, the polymorphism can affect the major conformation or the hydrophobicity of the surface of the binding interface. These findings are compatible with previous observations that suggested FCGR3A binding interface 3, 4 and may help in understanding the way the SNP affects the binding with Fc portion of human IgG1. 
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